Immucell (ICCC) Shares Outstanding (2010 - 2026)

Immucell (ICCC) has reported Shares Outstanding (Entity) for 17 consecutive years, with $9.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Shares Outstanding (Entity) changed 0.4% year-over-year to $9.1 million; the trailing twelve-month figure through Jun 2026 stood at $9.1 million (changed 0.4% YoY), and the FY2025 full-year result was $9.0 million, up 0.74% from the prior year.
• Shares Outstanding (Entity) held at $9.1 million in Q2 2026 per ICCC's latest filing, from $9.0 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $9.1 million in Q2 2026 and bottomed at $7.7 million in Q1 2022.
• Historically, Shares Outstanding (Entity) has averaged $8.3 million across 5 years, with a median of $7.8 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Entity) changed 0.0% in 2023, then grew 15.89% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $7.7 million in 2022, then advanced by 0.05% to $7.8 million in 2023, then climbed by 15.85% to $9.0 million in 2024, then advanced by 0.74% to $9.0 million in 2025, then grew by 0.4% to $9.1 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $9.1 million, $9.0 million, and $9.0 million for Q2 2026, Q4 2025, and Q3 2025 respectively.